Author

Aline Frick

University of California, San Francisco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1 Organism:zebrafish· 1

Frequent Co-Authors

Eline C. H. M. HaijeniD· 1 shared Johannes Gerardus RamaekersiD· 1 shared Kim P. C. KuypersiD· 1 shared Natasha Leigh MasoniD· 1 shared Pablo MallaroniiD· 1 shared Paige Whyte‐FagundesiD· 1 shared Scott C. BarabaniD· 1 shared Stefan W. ToennesiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Eline C. H. M. HaijenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants

Natasha Leigh Mason, Eline C. H. M. Haijen, Kim P. C. Kuypers, Aline Frick, Stefan W. Toennes, Pablo Mallaroni, Johannes Gerardus Ramaekers

This study finds that female participants report greater subjective intensity and impairment during acute psychedelic experiences compared to males, independent of drug exposure and age.

bioRxiv · Aug 19, 2026 · PreprintNeuroscience

Virtual screening and zebrafish phenotype-based evaluation argues against repurposing 4-phenylbutyrate for STXBP1-relateddisorders

Aline Frick, Paige Whyte‐Fagundes, Scott C. Baraban

The paper evaluates 4-PBA and its analogs for treating STXBP1 disorders using zebrafish models and finds no rescue of movement or seizure phenotypes.

Pharmacology Research & Perspectives · Jun 1, 2026Peer-reviewedPharmacology & Toxicology